| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $27.0M | +271.2% |
| Cost of Revenue | $19.1M | +181.1% |
| Gross Profit | $7.9M | +1578.9% |
| R&D Expense | $847K | -44.7% |
| SG&A Expense | $15.6M | +100.0% |
| Operating Income | -$9.8M | +11.1% |
| Net Income | -$9.8M | +8.6% |
| EPS (Basic) | -$0.64 | +54.0% |
| EPS (Diluted) | -$0.64 | +54.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $730K | +81.0% |
| Inventory | $307K | -49.3% |
| Current Assets | $23.1M | +185.4% |
| Total Assets | $63.4M | +81.4% |
| Current Liabilities | $11.1M | -31.1% |
| Total Liabilities | $14.9M | -54.6% |
| Stockholders' Equity | $48.6M | +2047.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.7M | -294.1% |
| Capital Expenditures | $23.7M | +1191.8% |
| Investing Cash Flow | -$23.7M | -1189.0% |
| Financing Cash Flow | $46.7M | +410.0% |
| Free Cash Flow | -$37.4M | -603.2% |